Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG et al
Case Number:
1:21-cv-01066
Court:
Nature of Suit:
Judge:
Firms
- Barclay Damon
- Bond Schoeneck
- Heslin Rothenberg
- King & Spalding
- Marshall Gerstein
- O'Melveny & Myers
- Paul Weiss
- Weil Gotshal
- White & Case
- Winston & Strawn
Companies
Sectors & Industries:
-
December 10, 2024
United Health Denials, Patent Antitrust Fight And Neb. Pot Law
United Healthcare must take a third look at its coverage denial for a patient's mental health and substance abuse treatment, and a former state senator asked the Nebraska Court of Appeals to wade into his fight against medical marijuana legalization. Here, Law360 Healthcare Authority looks at the significant cases and decisions that shaped the industry over the last week.
-
February 01, 2022
Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
A New York federal judge Monday tossed Regeneron Pharmaceuticals' antitrust lawsuit brought against rival Novartis Pharmaceuticals in response to Novartis' lawsuit claiming Regeneron infringed its patent related to a prefilled syringe treatment.